GBLX Projected Dividend Yield
GB Sciences Inc ( OTCBB : GBLX )GB Sciences is a phytomedical research and biopharmaceutical drug development company engaged in creating patented formulations of plant-inspired, therapeutic mixtures for the prescription drug market that target a variety of medical conditions. Co. is engaged in the research and development of plant-inspired medicines, primarily cannabinoid-inspired medicines, with virtual operations in North America and Europe. The intellectual property of Co.'s subsidiary, GbS Global Biopharma, Inc., covers a range of medical conditions and several programs are in the pre-clinical animal stage of development including Parkinson's disease, neuropathic pain, and cardiovascular therapeutic programs. 20 YEAR PERFORMANCE RESULTS |
GBLX Dividend History Detail GBLX Dividend News GBLX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |